Hong, W., Wang, K., Zhang, Y., Kou, J., Hong, D., Su, D., . . . Wang, X. (2013). Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population. Zhejiang University Press.
Style de citation ChicagoHong, Wei, et al. Methylenetetrahydrofolate Reductase C677T Polymorphism Predicts Response and Time to Progression to Gemcitabine-based Chemotherapy for Advanced Non-small Cell Lung Cancer in a Chinese Han Population. Zhejiang University Press, 2013.
Style de citation MLAHong, Wei, et al. Methylenetetrahydrofolate Reductase C677T Polymorphism Predicts Response and Time to Progression to Gemcitabine-based Chemotherapy for Advanced Non-small Cell Lung Cancer in a Chinese Han Population. Zhejiang University Press, 2013.